Mass balance and metabolism of Z-215, a novel proton pump inhibitor, in healthy volunteers

Ryoko TodaCentral Research Laboratories, Zeria Pharmaceutical Co., Ltd, Kumagaya, Saitama, Japan and Correspondence[email protected]

Tomoharu MiyagawaClinical Research, Research & Development, Zeria Pharmaceutical Co., Ltd, Chuo-ku, Tokyo, Japan

Yuka MasudaClinical Research, Research & Development, Zeria Pharmaceutical Co., Ltd, Chuo-ku, Tokyo, Japan

Yusuke HoshinoCentral Research Laboratories, Zeria Pharmaceutical Co., Ltd, Kumagaya, Saitama, Japan and

Kazuyoshi YoshiiCentral Research Laboratories, Zeria Pharmaceutical Co., Ltd, Kumagaya, Saitama, Japan and

Masamichi HirayamaCentral Research Laboratories, Zeria Pharmaceutical Co., Ltd, Kumagaya, Saitama, Japan and

Minaka ShibuyaCentral Research Laboratories, Zeria Pharmaceutical Co., Ltd, Kumagaya, Saitama, Japan and

Yoshihiro KawabataCentral Research Laboratories, Zeria Pharmaceutical Co., Ltd, Kumagaya, Saitama, Japan and

Your download is now in progress and you may close this window